Three-dimensional combined biomarkers assay could improve diagnostic accuracy for gastric cancer.

about

Three-dimensional combined biomarkers assay could improve diagnostic accuracy for gastric cancer.

Item

http://www.wikidata.org/entity/Q40039986

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Three-dimensional combined bio ...... c accuracy for gastric cancer.

@en

type

Item

label

Three-dimensional combined bio ...... c accuracy for gastric cancer.

@en

prefLabel

Three-dimensional combined bio ...... c accuracy for gastric cancer.

@en

P1476

Three-dimensional combined bio ...... c accuracy for gastric cancer.

@en

P2093

Huakang Tu

http://www.w3.org/2001/XMLSchema#string

Jingwei Liu

http://www.w3.org/2001/XMLSchema#string

Liping Sun

http://www.w3.org/2001/XMLSchema#string

Nannan Dong

http://www.w3.org/2001/XMLSchema#string

Quan Yuan

http://www.w3.org/2001/XMLSchema#string

Tiejun Chen

http://www.w3.org/2001/XMLSchema#string

Yuan Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis

Diagnostic value of osteopontin in ovarian cancer: a meta-analysis and systematic review

Osteopontin: role in cell signaling and cancer progression

Helicobacter pylori stimulates pepsinogen secretion from isolated human peptic cells

Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts.

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Serum OPN expression for identification of gastric cancer and atrophic gastritis and its influencing factors

Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer

Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer

Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study

P2888

s41598-017-12022-1

P304

11621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-12022-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28912586

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5599671

http://www.w3.org/2001/XMLSchema#string